GQCE testing

Policy / Regulatory

China’s CDE Releases 110th Batch of Reference Preparations for Generic Quality and Consistency Evaluation – 27 New Drugs Added in Draft Open for Public Feedback

China’s Center for Drug Evaluation (CDE) announced on September 7, 2026 the selection of the...

Policy / Regulatory

NMPA Issues 108th Batch Catalog of Reference Listed Drugs for Generic Drugs, Adding 17 New Specifications

Fineline Cube Aug 25, 2026

China’s National Medical Products Administration (NMPA) issued the Catalog of Reference Listed Drugs for Generic...

Policy / Regulatory

China’s CDE Releases 109th Reference Listed Drug Catalog, Adding 10 New Generic Drug Specifications

Fineline Cube Aug 6, 2026

The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) released the...

Policy / Regulatory

NMPA Releases 107th Batch of Reference Drugs for Generic Quality Consistency Evaluation, Adding 71 New Specifications

Fineline Cube Aug 4, 2026

China’s National Medical Products Administration (NMPA) announced the release of its 107th batch of reference...

Policy / Regulatory

China’s CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs

Fineline Cube Jun 29, 2026

China’s Center for Drug Evaluation (CDE) has released the 108th batch of reference preparations for...

Policy / Regulatory

NMPA Releases 106th Batch of Reference Drugs for Generic Quality Consistency Evaluation, Including BeOne Medicines’ Brukinsa (zanubrutinib)

Fineline Cube Jun 17, 2026

The National Medical Products Administration (NMPA) announced the 106th batch of reference drugs designated for...

Policy / Regulatory

NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications

Fineline Cube May 12, 2026

China’s National Medical Products Administration (NMPA) announced the release of the 105th batch of reference...

Company Drug

China’s CDE Releases 106th Batch of Chemical Generic Reference Preparations with 27 New Specifications and Updated Guidelines

Fineline Cube Apr 23, 2026

The Center for Drug Evaluation (CDE) under China’s National Medical Products Administration has published the...

Policy / Regulatory

NMPA Removes OCALIVA from GQCE Reference List – Obeticholic Acid Stripped Over Safety Concerns, Benefit-Risk Profile

Fineline Cube Mar 10, 2026

China’s National Medical Products Administration (NMPA) released the 102nd batch of reference drugs for generic...

Company Drug Policy / Regulatory

CDE Seeks Feedback on 103rd Batch of Generic Reference Preparations

Fineline Cube Feb 2, 2026

The Center for Drug Evaluation (CDE) is seeking industry feedback on the 103rd batch of...

Policy / Regulatory

CDE Reference Standards 101st Batch Seeks Public Feedback

Fineline Cube Dec 23, 2025

China’s Center for Drug Evaluation (CDE) announced it is seeking public feedback on the 101st...

Policy / Regulatory

NMPA Releases 98th RLD Catalog for Chemical Generics, Adding 48 New Specifications

Fineline Cube Nov 19, 2025

China’s National Medical Products Administration (NMPA) released the ninety-eighth batch of the Reference Listed Drugs...

Policy / Regulatory

China CDE Opens Public Comment on 100th Batch of Reference Standards for Chemical Generic Drugs

Fineline Cube Nov 5, 2025

The China Center for Drug Evaluation (CDE) has released a draft list of the 100th...

Policy / Regulatory

NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs

Fineline Cube Oct 24, 2025

China’s National Medical Products Administration (NMPA) today released its 98th Reference Listed Drugs (RLD) list...

Drug Policy / Regulatory

China CDE Seeks Public Feedback on 98th Batch of Reference Standards for Generic Drugs

Fineline Cube Sep 18, 2025

The China Center for Drug Evaluation (CDE) has published a draft list of the 98th...

Policy / Regulatory

NMPA Adds 35 New Reference‑Listed Drugs to 95th Catalog, Updates 31 Existing Specs

Fineline Cube Sep 3, 2025

The National Medical Products Administration (NMPA) today announced the release of its 95th Reference‑Listed Drugs...

Policy / Regulatory

CDE Seeks Feedback on 96th Batch of Chemical Generic Drug Reference Standards

Fineline Cube Jul 21, 2025

China’s Center for Drug Evaluation (CDE) is currently seeking public feedback on the 96th batch...

Policy / Regulatory

China’s CDE Announces 94th Batch of Reference Preparations for Generic Evaluation

Fineline Cube May 21, 2025

China’s Center for Drug Evaluation (CDE) has selected the 94th batch of reference preparations for...

Drug Policy / Regulatory

NMPA Releases 92nd Batch of Reference Drugs for Generic Quality Evaluation

Fineline Cube May 14, 2025

The National Medical Products Administration (NMPA) has released the 92nd batch of reference drugs for...

Policy / Regulatory

China’s CDE Reveals 93rd Batch of Reference Preparations for GQCE

Fineline Cube May 9, 2025

China’s Center for Drug Evaluation (CDE) has released the 93rd batch of reference preparations for...

GQCE testing

China’s CDE Releases 110th Batch of Reference Preparations for Generic Quality and Consistency Evaluation – 27 New Drugs Added in Draft Open for Public Feedback

NMPA Issues 108th Batch Catalog of Reference Listed Drugs for Generic Drugs, Adding 17 New Specifications

China’s CDE Releases 109th Reference Listed Drug Catalog, Adding 10 New Generic Drug Specifications

NMPA Releases 107th Batch of Reference Drugs for Generic Quality Consistency Evaluation, Adding 71 New Specifications

China’s CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs

NMPA Releases 106th Batch of Reference Drugs for Generic Quality Consistency Evaluation, Including BeOne Medicines’ Brukinsa (zanubrutinib)

NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications

China’s CDE Releases 106th Batch of Chemical Generic Reference Preparations with 27 New Specifications and Updated Guidelines

NMPA Removes OCALIVA from GQCE Reference List – Obeticholic Acid Stripped Over Safety Concerns, Benefit-Risk Profile

CDE Seeks Feedback on 103rd Batch of Generic Reference Preparations

CDE Reference Standards 101st Batch Seeks Public Feedback

NMPA Releases 98th RLD Catalog for Chemical Generics, Adding 48 New Specifications

China CDE Opens Public Comment on 100th Batch of Reference Standards for Chemical Generic Drugs

NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs

China CDE Seeks Public Feedback on 98th Batch of Reference Standards for Generic Drugs

NMPA Adds 35 New Reference‑Listed Drugs to 95th Catalog, Updates 31 Existing Specs

CDE Seeks Feedback on 96th Batch of Chemical Generic Drug Reference Standards

China’s CDE Announces 94th Batch of Reference Preparations for Generic Evaluation

NMPA Releases 92nd Batch of Reference Drugs for Generic Quality Evaluation

China’s CDE Reveals 93rd Batch of Reference Preparations for GQCE

You Missed

Hainan Boao Lecheng Pilot Zone Issues Exit Mechanism Rules for Clinical Translation of New Biomedical Technologies – Full‑Process Framework for Suspension, Exit and Resumption

BRL Medicine’s Allogeneic CD19 CAR‑T Included in CDE’s “Care Program‑Extension” – Rare Disease Fast Track for Relapsed/Refractory Systemic Sclerosis

Walvax’s Third‑Generation COVID‑19 mRNA Vaccine Wins NMPA Approval – JN.1‑Based Shot Clears Regulatory Bar for Adults in China

China’s Seventh National VBP Round for Medical Consumables Concludes in Tianjin – 517 Digestive Intervention Products Selected Across 23 Categories